Sexual dysfunction is increasingly being recognized as a significant yet under-addressed complication in women with Sjögren’s syndrome, with recent studies highlighting its high prevalence and …
Serum biomarkers have long been investigated for their potential to aid diagnosis, prognosis, disease monitoring, and treatment response in JIA. Despite decades of research, however, …
A novel anti-CD38 monoclonal antibody, CM313, has demonstrated a manageable safety profile and encouraging early clinical efficacy in patients with systemic lupus erythematosus (SLE), according to results …
A new study published in The Lancet has found that two years of treatment with anti–interleukin-5/receptor (IL-5/R) therapy leads to durable remission, reduced oral glucocorticoid …
A recent study published in Rheumatic and Musculoskeletal Diseases Open found that elevated baseline levels of complement activation marker C3dg and complement proteases MASP-1 and MASP-3 predicted …
A new study published in The Lancet has found that nipocalimab, a neonatal Fc receptor (FcRn) blocker, significantly reduces clinical disease activity in patients with …
A new study published in Inflammopharmacology reports that L-carnitine, when administered alongside conventional disease-modifying antirheumatic drugs (DMARDs), may significantly improve clinical symptoms and reduce systemic inflammation in …
A new study published in Annals of the Rheumatic Diseases reports that patients with rheumatoid arthritis (RA) who receive Janus kinase inhibitors show a small …
A recent study published in Current Rheumatology Reviews found that high dose omega 3 supplementation significantly improved fibromyalgia pain measures and was associated with increased serum magnesium …